{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:08:49Z","timestamp":1790244529112,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102777"],"award-info":[{"award-number":["82102777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To investigate the distribution and molecular characteristics of\n                      <jats:italic>MTAP<\/jats:italic>\n                      rearrangements in pediatric acute lymphoblastic leukemia (ALL) and assess their impact on clinical features, treatment response, and prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed 338 pediatric ALL patients. Patients were stratified into two cohorts based on\n                      <jats:italic>MTAP<\/jats:italic>\n                      rearrangement status: the\n                      <jats:italic>MTAP<\/jats:italic>\n                      \u2010r group and the non\u2010\n                      <jats:italic>MTAP<\/jats:italic>\n                      \u2010r group. Baseline clinical characteristics, molecular profiles, and induction therapy responses were compared between the groups. Prognostic outcomes were also evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 338 pediatric ALL patients, 32 (9.47%) harbored\n                      <jats:italic>MTAP<\/jats:italic>\n                      rearrangements. Compared to the non\n                      <jats:italic>\u2010MTAP<\/jats:italic>\n                      \u2010r group, patients in the\n                      <jats:italic>MTAP<\/jats:italic>\n                      \u2010r group demonstrated a significantly higher proportion of T\u2010ALL (\n                      <jats:italic>p\u00a0<\/jats:italic>\n                      &lt;\u00a00.05), elevated peripheral WBC counts at diagnosis, higher LDH levels, and were more frequently classified into intermediate\u2010\/high\u2010risk groups (\n                      <jats:italic>p\u00a0<\/jats:italic>\n                      &lt;\u00a00.05). Five distinct\n                      <jats:italic>MTAP<\/jats:italic>\n                      rearrangement patterns were identified, with\n                      <jats:italic>MTAP::CDKN2B\u2010AS1<\/jats:italic>\n                      being the most prevalent (75.0%). Regarding mutational profiles,\n                      <jats:italic>MTAP<\/jats:italic>\n                      \u2010r patients exhibited a higher frequency of mutations in\n                      <jats:italic>NOTCH1<\/jats:italic>\n                      ,\n                      <jats:italic>PTEN<\/jats:italic>\n                      ,\n                      <jats:italic>FBXW7<\/jats:italic>\n                      ,\n                      <jats:italic>SRCAP<\/jats:italic>\n                      , and\n                      <jats:italic>USP7<\/jats:italic>\n                      . Furthermore, the mutated genes were significantly enriched in pathways related to viral carcinogenesis, immune evasion, and metabolic signaling. Patients with\n                      <jats:italic>MTAP<\/jats:italic>\n                      \u2010r ALL exhibited significantly inferior outcomes compared to those in the non\u2010\n                      <jats:italic>MTAP<\/jats:italic>\n                      \u2010r group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>MTAP<\/jats:italic>\n                      rearrangement defines a distinct and clinically adverse subset of pediatric ALL characterized by specific fusion architecture and an unfavorable co\u2010mutation pattern. Beyond its diagnostic value,\n                      <jats:italic>MTAP<\/jats:italic>\n                      \u2010r represents a promising biomarker for trial enrollment and future risk\u2010adapted strategies. Confirmation of independent prognostic impact and therapeutic utility will require multivariable analyses and prospective, biomarker\u2010driven studies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/mpo.70012","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T07:56:56Z","timestamp":1763625416000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Impact of\n                    <i>MTAP<\/i>\n                    Rearrangement in Pediatric Acute Lymphoblastic Leukemia: Insights From Whole Transcriptome Analysis"],"prefix":"10.1002","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6310-6155","authenticated-orcid":false,"given":"Sidong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pediatrics The First Affiliated Hospital of Zhengzhou University  Zhengzhou China"},{"name":"Department of Pediatrics State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases Institute of Hematology &amp; Blood Diseases Hospital Chinese Academy of Medical Sciences &amp; Peking Union Medical College  Tianjin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy The First Affiliated Hospital of Zhengzhou University  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics The First Affiliated Hospital of Zhengzhou University  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics The First Affiliated Hospital of Zhengzhou University  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3067-5039","authenticated-orcid":false,"given":"Yadong","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy The First Affiliated Hospital of Zhengzhou University  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33018-1"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.234"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.10.013"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023754"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-144790"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.168"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102724"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0399"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13697"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2023.04.003"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11790"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02238"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-20-0229"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.14.6489"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.12.6203"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145647"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36404-w"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03823-8"},{"issue":"8","key":"e_1_2_9_20_1","first-page":"2082","article-title":"Characterization of Methylthioadenosin Phosphorylase (MTAP) Expression in Colorectal Cancer","volume":"46","author":"Zhong Y.","year":"2018","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0669"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2002.0483"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.11.7.14948"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2016.1251518"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.8.3083.bloodjournal8883083"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1173356"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-0414"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad5944"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13587"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.09.005"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953721"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2021.10.006"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-963"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.42970"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2023.11.003"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.03.043"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-1644"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad073.151"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz200"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105492"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3265.BLADDER24-B027"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-4536"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpo.70012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mpo.70012","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpo.70012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:37:28Z","timestamp":1790242648000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpo.70012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1002\/mpo.70012"],"URL":"https:\/\/doi.org\/10.1002\/mpo.70012","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"2025-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70012"}}